Thursday 15 November 2018
Home      All news      Contact us     
cbsnews.com - 5 month ago

Whistleblower: Purdue Pharma continued deceptive sales practices for OxyContin after 2007

A former sales representative for Purdue Pharma? tells CBS News Tony Dokoupil that the drug maker continued to engage in deceptive sales practices for its opiate painkiller OxyContin later than the company previously acknowledged. Carol Panara joined Purd

Related news

Latest News
Hashtags:   

Whistleblower

 | 

Purdue

 | 

Pharma

 | 

continued

 | 

deceptive

 | 

sales

 | 

practices

 | 

OxyContin

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Sources